Eton Pharmaceuticals, Inc.
ETON · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,927 | -$2,585 | -$1,572 | -$598 |
| Dep. & Amort. | $1,009 | $1,005 | $1,013 | $355 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,092 | $2,096 | $1,200 | $0 |
| Change in WC | $10,344 | $6,175 | -$4 | -$2,360 |
| Other Non-Cash | $1,508 | $1,268 | $1,453 | $1,838 |
| Operating Cash Flow | $12,026 | $7,959 | $2,090 | -$765 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$284 | $0 | $0 | -$8,132 |
| Net Acquisitions | $0 | $0 | $0 | -$30,000 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$284 | $0 | $0 | -$38,132 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $25,309 |
| Stock Issued | $0 | $0 | $394 | $8,015 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $248 |
| Financing Cash Flow | $0 | $0 | $394 | $33,572 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $11,742 | $7,959 | $2,484 | -$5,325 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25,379 | $17,420 | $14,936 | $20,261 |
| End Cash | $37,121 | $25,379 | $17,420 | $14,936 |
| Free Cash Flow | $11,742 | $7,959 | $2,090 | -$777 |